Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

BACKGROUND: Toxicity from chemotherapy is highly variable, unpredictable and results in substantial morbidity and increased healthcare costs. New predictors of toxicity are required to improve the safety and efficacy of chemotherapy. Inflammatory or B symptoms in lymphoma are associated with elevate...

詳細記述

保存先:
書誌詳細
主要な著者: Sharma, Rohini, Cunningham, David, Smith, Paul, Robertson, Graham, Dent, Owen, Clarke, Stephen J
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2009
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689869/
https://ncbi.nlm.nih.gov/pubmed/19450285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-153
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料